SPEAKERS

André Picard

Author and Journalist, Health Reporter and Columnist

Daniel MacDonald

Director General, Drugs for Rare Diseases

Dr. Patricia Caetano

Director, Drug Data Services and Analytics

Tijana Fazlagic

Executive Director, PharmaCare Benefits Branch

Sylvie Bouchard

Director, Drug Evaluation and Technology Assessment for Reimbursement

Amanda Allard, Director

Director, Pharmaceutical Reviews

Carol Stiff

General Manager

Ali Ghiassi

VP Industry Affairs & Government Relations

Stephanie Di Trapani

A/Director, Drug Shortages Division

Dennis Chan

Principal Consultant

Courtney Abunassar

Associate Director, Market Access and Policy Research

Ned Pojskic

Vice President, Pharmacy Benefits Management

Dr. Daria O’Reilly

Lead Health Economist

Alex Chambers

Senior Market Access Manager

Donald Allard

B.Pharm., D.P.H., Director, Government Relations and Public Affairs

Jim Keon

President

Jason Grier

President and CEO

Dylan Lamb-Palmer

Associate Director, Pricing and Data Analytics

Julie Totten

Managing Director

Lindy Forte

Senior Vice President, Market Access and Pricing

John-Paul Dowson

Director, Strategic Consulting

Luisa Restrepo

Senior Manager, Market Access

Bobby Currie

Manager of Pharmaceutical Relations

Christine Donaldson

President and CEO

Kim Steele

Director, Government and Community Relations

Dr. Stéphanie Michaud

President and Chief Executive Officer

Brad Millson

GM, Real World Solutions

Sean McBride

Head, Commercial Operations

Glen Doucet

Chief Executive Officer

Imran Ali

Director, Federal Policy & Provincial Affairs – Ontario & Atlantic

Rosemarie Childerhose

Director of Market Access and Pricing

Louise St-Onge

Lead, Market Access and Government Affairs Canada

Jody Engel, MScA

Country Manager Canada

Angelique Berg

Chief Executive Officer

Tammy Moore

Chief Executive Officer

Linda Wilhelm

President

Declan Hamill

Vice President, Legal, Regulatory Affairs and Compliance

Kate Lee

Vice President, Research & Patient Programs

Dr. Mina Tadrous

Assistant Professor, Leslie Dan Faculty of Pharmacy, and Investigator - Ontario Drug Policy Research Network

Dr. Joel Lexchin

Professor, Institute of Health Policy, Management and Evaluation

Paul Grootendorst

Associate Professor, Leslie Dan Faculty of Pharmacy

Mark Smithyes

Former Chair, Current Director

Belinda Yap

Director, Health Economics and Outcomes Research

Alison Vanlerberghe

Market Access Lead